U.S. markets closed

Intercept Pharmaceuticals, Inc. (ICPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.26-0.89 (-4.90%)
At close: 4:00PM EDT

17.26 -0.00 (-0.00%)
After hours: 4:53PM EDT

Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
321,699
312,690
252,002
179,804
130,956
Cost of Revenue
5,280
5,322
4,212
2,519
1,371
Gross Profit
316,419
307,368
247,790
177,285
129,585
Operating Expense
478,770
523,978
560,217
462,775
465,197
Operating Income
-162,351
-216,610
-312,427
-285,490
-335,612
Net Non Operating Interest Income Expense
-48,696
-48,054
-41,144
-30,523
-29,271
Other Income Expense
-11,270
-10,216
8,890
6,771
4,516
Pretax Income
-222,317
-274,880
-344,681
-309,242
-360,367
Net Income Common Stockholders
-222,317
-274,880
-344,681
-309,242
-360,367
Diluted NI Available to Com Stockholders
-222,317
-274,880
-344,681
-309,242
-360,367
Basic EPS
-
-
-10.89
-10.86
-14.38
Diluted EPS
-
-
-10.89
-10.86
-14.38
Basic Average Shares
-
-
31,654
28,464
25,054
Diluted Average Shares
-
-
31,654
28,464
25,054
Total Operating Income as Reported
-177,142
-231,240
-312,427
-285,490
-335,612
Total Expenses
484,050
529,300
564,429
465,294
466,568
Net Income from Continuing & Discontinued Operation
-222,317
-274,880
-344,681
-309,242
-360,367
Normalized Income
-207,526
-260,250
-344,681
-309,242
-360,367
Interest Expense
48,696
48,054
41,144
30,523
29,271
Net Interest Income
-48,696
-48,054
-41,144
-30,523
-29,271
EBIT
-173,621
-226,826
-303,537
-278,719
-331,096
EBITDA
-170,397
-
-
-
-
Reconciled Cost of Revenue
5,280
5,322
4,212
2,519
1,371
Reconciled Depreciation
3,224
3,118
3,663
4,582
4,601
Net Income from Continuing Operation Net Minority Interest
-222,317
-274,880
-344,681
-309,242
-360,367
Total Unusual Items Excluding Goodwill
-14,791
-14,630
-
-
-
Total Unusual Items
-14,791
-14,630
-
-
-
Normalized EBITDA
-155,606
-209,078
-299,874
-274,137
-326,495
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0